The inventory plummets after disappointing information on Novo Nordisk’s drug candidate cagrisema for the remedy of weight problems in a long-awaited section 3 trial.
发布者:BY MARIA OUTZE NIELSEN,转转请注明出处:https://robotalks.cn/novo-nordisk-disappoints-with-data-on-anti-obesity-hope-in-long-awaited-study/